Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
1 x
$
30.00
View Cart
Checkout
Home
Misdiagnosis of Catatonia (OPEN ACCESS)
“A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders” has been added to your cart.
View cart
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Misdiagnosis of Catatonia (OPEN ACCESS) quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
VOL 50 No. 1 Articles 2020
,
Open Access Articles
Tags:
Agastya Nayar
,
benzodiazepines
,
catatonia
,
feras-ali-mustafa
,
lorazepam challenge
,
memantine
,
misdiagnosis
Description
Description
Letter to the Editor
Misdiagnosis of Catatonia
By Feras Ali Mustafa, Agastya Nayar
Related products
Use of Clozapine in the General Hospital (OPEN ACCESS)
$
0.00
Add to cart
Details
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
The Effect of Organic Lithium Salts on Plasma 8-Hydroxy-2’-Deoxyguanosine in Bipolar Patients In Vitro
$
30.00
Add to cart
Details
Page load link
Go to Top